Vorinostat-loaded titanium oxide nanoparticles (anatase) induce G2/M cell cycle arrest in breast cancer cells via PALB2 upregulation
Author(s) -
Shaimaa Abdel-Ghany,
Sara Raslan,
Hüseyin Tombuloğlu,
Aly Shamseddin,
Emre Cevik,
Osama A. M. Said,
Engy F. Madyan,
Mehmet Şenel,
Ayhan Bozkurt,
Suriya Rehman,
Hussein Sabit
Publication year - 2020
Publication title -
3 biotech
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 0.557
H-Index - 37
eISSN - 2190-572X
pISSN - 2190-5738
DOI - 10.1007/s13205-020-02391-2
Subject(s) - vorinostat , cancer research , breast cancer , cancer cell , pancreatic cancer , histone deacetylase inhibitor , cancer , chemistry , erlotinib , apoptosis , medicine , pharmacology , histone deacetylase , epidermal growth factor receptor , histone , biochemistry , gene
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom